Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation for Postoperative Pain: A Meta-Analysis of Randomized Controlled Trials.
Journal
Pain research & management
ISSN: 1918-1523
Titre abrégé: Pain Res Manag
Pays: United States
ID NLM: 9612504
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
01
2022
accepted:
29
03
2022
entrez:
25
4
2022
pubmed:
26
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
This meta-analysis aims to evaluate the effectiveness and safety of transcutaneous electrical acupoint stimulation (TEAS) in treating post-operative pain. This meta-analysis was registered in PROSPERO (CRD42021286753). We searched PubMed, Embase, and the Cochrane Library for relevant randomized controlled trials (RCTs) about TEAS in treating postoperative pain that were published before November 2021. The primary outcome was visual analogue scale (VAS) within 24 h after surgery. The secondary outcomes included postoperative opioid analgesic drug consumption and the occurrence of adverse reactions within the postoperative 24-72 h. Adverse reactions included dizziness, nausea, and vomiting. Continuous variables were analyzed using mean difference (MDs) or standardized mean difference (SMDs) and 95% CIs. Relative risk (RR) and 95% CI were used for dichotomous data. The data were pooled and analyzed by RevMan 5.4 and STATA15.0 software. Seventeen trials with 1375 participants were included. The current results suggested that application of TEAS showed obvious superiority in reducing VAS scores (SMD = -1.51, 95% CI = -2.20∼-0.82, I2 = 96%). Subgroup analysis was performed according to open surgery and minimally invasive surgery. VAS scores were decreased after surgery at 24 h (SMD = -0.84, 95% CI = -1.07∼-0.6, I2 = 96%; SMD = -0.88, 95% CI = -1.02∼-0.75, I2 = 96%). The incidence of postoperative dizziness and nausea and vomiting was significantly lower in the TEAS group within postoperative 24-72 h (RR = 0.48, 95% CI = 0.34∼0.68, I2 = 0%; RR = 0.66, 95% CI = 0.44∼1.01, I2 = 69%; and RR = 0.49, 95% CI = 0.24∼1.00, I2 = 51%). Postoperative opioid analgesics were also reduced in the TEAS group within 72 h after surgery (SMD = -2.10, 95% CI = -3.37∼-0.82, I2 = 96%). TEAS can reduce postoperative pain as well as the incidence of dizziness, nausea, and vomiting and the number of analgesics used after surgery. TEAS is a reasonable modality to incorporate into a multimodal management approach for postoperative pain.
Identifiants
pubmed: 35463630
doi: 10.1155/2022/7570533
pmc: PMC9023215
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
7570533Informations de copyright
Copyright © 2022 Dan Wang et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Neuromodulation. 2020 Aug;23(6):838-846
pubmed: 32472663
Int J Surg. 2020 Jan;73:57-64
pubmed: 31704425
Lancet. 2006 May 13;367(9522):1618-25
pubmed: 16698416
Life Sci. 2020 Nov 15;261:118473
pubmed: 32971101
Nat Sci Sleep. 2020 Oct 27;12:809-819
pubmed: 33154688
JAMA Surg. 2017 Nov 01;152(11):1066-1071
pubmed: 28768328
Clin J Pain. 2017 Apr;33(4):340-347
pubmed: 27437568
Exp Ther Med. 2021 Mar;21(3):184
pubmed: 33488793
J Leukoc Biol. 2020 Jul;108(1):189-198
pubmed: 32645257
Br J Anaesth. 2019 Jun;122(6):705-707
pubmed: 31005244
J Pain. 2003 Jun;4(5):231-56
pubmed: 14622694
Urolithiasis. 2019 Jun;47(3):279-287
pubmed: 29557487
Lasers Med Sci. 2016 Nov;31(8):1645-1649
pubmed: 27495129
Anaesthesia. 2014 Aug;69(8):832-9
pubmed: 24865978
Evid Based Complement Alternat Med. 2015;2015:324360
pubmed: 26170873
Eur J Anaesthesiol. 2016 Mar;33(3):160-71
pubmed: 26509324
Magn Reson Imaging. 2013 Sep;31(7):1105-11
pubmed: 23684242
Ann Palliat Med. 2020 Sep;9(5):2538-2544
pubmed: 32954744
Neurosurgery. 2016 Aug;63 Suppl 1:43-51
pubmed: 27399363
Nat Rev Cardiol. 2020 Sep;17(9):574-584
pubmed: 32322101
JAMA Surg. 2017 Jul 1;152(7):691-697
pubmed: 28564673
J Clin Med. 2021 Jan 04;10(1):
pubmed: 33406735
Int J Clin Exp Med. 2015 May 15;8(5):7754-61
pubmed: 26221326
Anesth Analg. 1997 Aug;85(2):406-13
pubmed: 9249122
Anesth Prog. 2012 Summer;59(2):90-101; quiz 102-3
pubmed: 22822998
Pain. 2020 Sep 1;161(9):1976-1982
pubmed: 32694387
Adv Exp Med Biol. 2020;1191:141-153
pubmed: 32002927
Int Rev Neurobiol. 2013;111:1-23
pubmed: 24215915
Acupunct Med. 2015 Aug;33(4):270-6
pubmed: 25926298
Int J Nurs Stud. 2011 Jun;48(6):703-9
pubmed: 21122849
Biol Psychiatry. 1998 Jul 15;44(2):129-38
pubmed: 9646895
Clin Nurs Res. 2018 May;27(4):450-466
pubmed: 28071133
Cancer Manag Res. 2021 Feb 12;13:1449-1458
pubmed: 33603487
Prog Neurobiol. 2008 Aug;85(4):355-75
pubmed: 18582529
Trials. 2020 Jan 8;21(1):43
pubmed: 31915045
Surg Clin North Am. 2015 Apr;95(2):301-18
pubmed: 25814108
Acupunct Med. 2015 Feb;33(1):65-71
pubmed: 25324276
Ann Phys Rehabil Med. 2018 Sep;61(5):339-344
pubmed: 29958963
J Pain. 2018 May;19(5):455-474
pubmed: 29198932
Evid Based Complement Alternat Med. 2012;2012:627023
pubmed: 23346208
Biomedicines. 2021 Jul 26;9(8):
pubmed: 34440101
Exp Neurol. 2005 Mar;192(1):156-62
pubmed: 15698629
J Neuroinflammation. 2019 Dec 13;16(1):264
pubmed: 31836020
Brain Behav Immun. 2020 Oct;89:604-614
pubmed: 32640285
Thorac Cancer. 2020 Apr;11(4):928-934
pubmed: 32062864